The regulation, and the interpretation of existing rules, of cannabis in all its forms is a recurring subject in France, and which should continue following the recent decision of the Court of Justice of the European Union (CJEU) in the case Kanavape. Besides the changes related to this, there are a number of other proposals relating to the French medical cannabis regime. This report gives a detailed overview of all current and possible future regulations.
The recent CJEU ruling is likely to have far-reaching consequences for the European CBD industry, and although France has yet to release an interpretation, the government will have no choice but to decide. adapt to the decision.
This report will provide you with everything you need to know about the French regulatory framework for CBD and cannabis, from the processing and cultivation of hemp to the country’s medical and recreational regimes.
Main topics covered:
- Hemp plant
- Extracts as a finished product
- Finished products containing CBD and extracts
- Import and export requirements
- Enforcement measures
- Medical Cannabis
- Recreational cannabis
- Relevant laws
- Organizations concerned
For more information on this report, visit https://www.researchandmarkets.com/r/l7pl7y
ResearchAndMarkets.com is the world’s leading source for market research reports and international market data. We provide you with the latest data on international and regional markets, key industries, major companies, new products and the latest trends.